PathAI is at the forefront of developing and applying artificial intelligence (AI) to the field of pathology. Their mission is to improve patient outcomes with AI-powered pathology. PathAI's solutions assist pathologists in making more accurate and efficient diagnoses, aid biopharmaceutical companies in accelerating drug development by providing quantitative insights from tissue samples, and support researchers in uncovering new biological understanding. By leveraging machine learning and deep learning, PathAI aims to transform the analysis of medical images, ultimately contributing to advancements in precision medicine and better healthcare for all.
Serves as the central hub for research and development, engineering, product management, business operations, and corporate leadership, driving PathAI's mission to advance medicine with intelligent pathology.
Modern office space designed to foster collaboration and innovation, featuring open-plan work areas, advanced research facilities, and state-of-the-art computing infrastructure required for AI development. The environment is tailored to support a high-tech, research-intensive company.
PathAI cultivates a mission-driven work culture focused on innovation, collaboration, and impact. Employees are passionate about leveraging AI to solve complex healthcare challenges. The environment encourages continuous learning, interdisciplinary teamwork between AI scientists, software engineers, pathologists, and business professionals, and a commitment to scientific rigor and ethical AI development.
The Boston headquarters is significant due to its proximity to world-class academic institutions, leading hospitals, a vibrant biotech ecosystem, and a rich talent pool in AI and life sciences. This location facilitates collaborations, partnerships, and recruitment of top talent, crucial for PathAI's growth and innovation.
PathAI supports global biopharmaceutical companies, contract research organizations (CROs), and academic institutions in their research and clinical trial activities worldwide. While its physical offices are primarily in the USA, PathAI's AI-powered platforms and services are utilized by partners across North America, Europe, and Asia to analyze pathology data, streamline drug development pipelines, and advance biomarker discovery on a global scale. Their digital pathology solutions enable remote collaboration and standardized analysis, transcending geographical boundaries.
179 South Street
Boston
MA
USA
Address: 6000 Fletcher Creek Cove, Memphis, TN 38133
The Memphis location provides a central US hub for PathAI's diagnostic laboratory operations, enabling efficient sample processing, service delivery across the region, and supporting the company's expansion into clinical diagnostics with real-world application of its AI models.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, PathAI' leadership includes:
PathAI has been backed by several prominent investors over the years, including:
PathAI has strategically strengthened its leadership with key appointments, such as a new Vice President of Medical Affairs, over the past year. The core C-suite team has demonstrated stability with no major publicly announced departures, allowing the company to focus on its growth and innovation objectives.
Discover the tools PathAI uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
PathAI commonly utilizes an email format consisting of the employee's first initial followed by their last name. This pattern is prevalent within the organization for professional correspondence.
[first_initial][last]@pathai.com
Format
jdoe@pathai.com
Example
70%
Success rate
Business Wire • February 27, 2024
PathAI has launched its AISlide™ Suite, a set of AI-powered tools designed to help pathology laboratories adopt and integrate artificial intelligence into their workflows. The suite aims to improve efficiency and provide quantitative insights for pathologists, facilitating broader AI adoption in diagnostics....more
Business Wire • January 8, 2024
PathAI and Roche are broadening their partnership to co-develop and distribute AI-driven pathology algorithms for companion diagnostics. This collaboration aims to accelerate the development of new targeted therapies by enhancing biomarker assessment and supporting personalized medicine....more
Business Wire • October 26, 2023
PathAI has strengthened its board with the appointment of Dr. Mike Poole, who brings extensive experience in diagnostics and pharmaceutical R&D. This addition is expected to provide valuable strategic guidance as PathAI continues to innovate in AI-powered pathology....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including PathAI, are just a search away.